Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Accounts receivable, allowance	$ (22,222)	$ (21,647)
Deferred financing costs	$ (14,568)	$ (10,578)
Common shares, par value (in USD per share)	$ 0.01	$ 0.01
Common shares, shares authorized (in shares)	500,000,000	500,000,000
Common shares, shares issued (in shares)		283,699,120
Common shares, shares outstanding (in shares)		283,699,120